Level and value of interleukin-18 in patients with acute myocardial infarction undergoing primary coronary angioplasty

Circulation Journal

Volumn 71, Issue 5, 2007, Pages 703-708

  Youssef, Ali A ^a   Chang, Li Teh ^b   Hang, Chi Ling ^c   Wu, Chiung Jen ^c   Cheng, Cheng I ^c   Yang, Cheng Hsu ^c   Sheu, Jiunn Jye ^d   Chai, Han Tan ^c   Chua, Sarah ^c   Yeh, Kuo Ho ^c   Yip, Hon Kan ^c,e  

^a Suez Canal University Hospital   (Egypt)

^b MEIHO UNIVERSITY   (Taiwan)

^c Division of Cardiology   (Taiwan)

^d CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^e CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Acute myocardial infarction; Interleukin 18; Major adverse clinical outcomes

Indexed keywords

ACETYLSALICYLIC ACID; AUTACOID; CLOPIDOGREL; CREATINE KINASE MB; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; INTERLEUKIN 18; TIROFIBAN;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CARDIOGENIC SHOCK; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROTEIN BLOOD LEVEL; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ANGIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; INTERLEUKIN-18; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; RISK FACTORS; SHOCK, CARDIOGENIC; STROKE VOLUME; TIME FACTORS;

EID: 34247609368     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.71.703     Document Type: Article

References (38)

1. Ross R. Atherosclerosis: An inflammatory disease. N Engl J Med 1999; 340: 115-126.
2. Yip HK, Sun CK, Chang LT, Wu CJ. Strong correlation between serum levels of inflammatory mediators and their distribution in infarct-related coronary artery. Circ J 2006; 70: 838-845.
3. Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation 1995; 92: 657-761.
4. Burke AP, Tracy RP, Kologie F, Malcom GT, Zieske A, Kutys R, et al. Elevated C-reactive protein values and atherosclerosis in sudden coronary death: Association with different pathologies. Circulation 2002; 105: 2019-2023.
5. Lee RT, Libby P. The unstable atheroma. Arterioscler Thromb Vasc Biol 1997; 17: 1859-1867.
6. Mallat Z, Corbaz A, Scoazec A, Besnard S, Leseche G, Chvatchko Y, et al. Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability. Circulation 2001; 104: 1598-1603.
7. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002; 105: 1135-1143.
8. Maier W, Altwegg LA, Corti R, Gay S, Hersberger M, Maly FE, et al. Inflammatory markers at the site of rupture plaque in acute myocardial infarction. Circulation 2005; 111: 1355-1361. 9. Neumann FJ, Ott I, Gawaz M, Richardt G, Holzapfel H, Jochum M, et al. Cardiac release of cytokines and inflammatory response in acute myocardial infarction. Circulation 1995; 92: 748-755.
9. Ono K, Matsumori A, Shioi T, Furukawa Y, Sasayama S. Cytokine gene expression after myocardial infarction in rat hearts: Possible implication in left ventricular remodeling. Circulation 1998; 98: 149-156.
10. Valgimigli M, Ceconi C, Malagutti P, Merli E, Soukhomovskaia O, Francolini G, et al. Tumor necrotic factor-alpha receptor 1 is a major predictor of mortality and new-onset heart failure in patients with acute myocardial infarction. Circulation 2005; 111: 863-870.
11. Cusack MR, Marber MS, Lambiase PD, Bucknall CA, Redwood SR. Systemic inflammation in unstable angina is the result of myocardial necrosis. J Am Coll Cardiol 2002; 39: 1917-1923.
12. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH. Plasma concentration of interleukin-6 and risk of future myocardial infarction among apparently healthy men. Circulation 2000; 101: 1767-1772.
13. Blankenberg S, Luc G, Ducimetiere P, Arveiler D, Ferrieres J, Amouyel P, et al. Interleukin-18 and risk of coronary heart disease in European men: The Prospective Epidemiological Study of Myocardial Infarction (PRIME). Circulation 2003; 108: 2453-2459.
14. Ghayur T, Banerjee S, Hugunin M, Butler D, Herzog L, Carter A, et al. Caspase-1 processes IFN-gamma-inducing factor and regulate LPS-induced IFN-gamma production. Nature 1997; 368: 619-623.
15. Gu Y, Kuida K, Tsutsui H, Ku G, Hsiao K, Fleming MA, et al. Activation of interferon-gamma inducing factor medicated by interleukin-1 beta converting enzyme. Science 1997; 275: 206-209.
16. Okamura H, Tsutsi H, Komatsu T, Yutsudo M, Hakura A, Tanimoto T, et al. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 1995; 378: 88-89.
17. Libby P. Molecular bases of the acute coronary syndromes. Circulation 1995; 91: 2844-2850.
18. Gupta S, Pablo AM, Jiang X, Wang N, Tall AR, Schindler C. IFN-gamma potentiates atherosclerosis in ApoE knock-out mice. J Clin Invest 1997; 99: 2752-2761.
19. Okamura H, Tsutsui H, Kashiwamura S, Yoshimoto T, Nakanishi K. Interleukin-18: A novel cytokine that augments both innate and acquired immunity. Adv Immunol 1998; 70: 281-312.
20. Gracie JA, Robertson SE, McInnes IB. Interleukin-18. J Leukoc Biol 2003; 73: 213-224.
21. Mallat Z, Corbaz A, Scoazec A, Besnard S, Lesèche g, Chvatchko Y, et al. Interleukin-18/interleukin-18 binding protein signaling modulates atherosclerotic lesion development and stability. Circ Res 2001; 89: E41-E45.
22. Whitman SC, Ravisankar P, Daugherty A. Interleukin-18 enhances atherosclerosis in apolipoprotein E (-/-) mice through release of interferon-gamma. Circ Res 2002; 90: E34-E38.
23. Tiret L, Godefroy T, Lubos E, Nicaud V, Tregouet DA, Barbaux S, et al. Genetic analysis of the interleukin-18 system highlights the role of the interleukin-18 gene in cardiovascular disease. Circulation 2005; 112: 643-650.
24. Seta Y, Kanda T, Tanaka T, Arai M, Sekiguchi K, Yokoyama T, et al. Interleukin 18 in acute myocardial infarction. Heart 2000; 84: 668-669.
25. Yip HK, Wu CJ, Chang HW, Hsieh YK, Fang CY, Chen MC, et al. Impact of tirofiban on angiographic morphologic features of high-burden thrombus formation during direct percutaneous coronary intervention and short-term outcomes. Chest 2003; 124: 962-968.
26. Yip HK, Wu CJ, Chang HW, Fang CY, Yang CH, Chen SM, et al. Effect of the PercuSurge GuardWire Device on the integrity of microvasculature and clinical outcomes during primary transradial coronary intervention in acute myocardial infarction. Am J Cardiol 2003; 92: 1331-1335.
27. Goldberg RJ, Gore JM, Alpert JS, Osganian V, de Groot J, Bade J, et al. Cardiogenic shock after acute myocardial infarction: Incidence and mortality from a community-wide perspective, 1875-1988. N Engl J Med 1991; 325: 1117-1122.
28. Yip HK, Wu CJ, Chang HW, Hang CL, Fang CY, Hsieh YK, et al. Comparison of primary angioplasty and conservative treatment on short- and long-term outcome in octogenarian or older patients with acute myocardial infarction. Jpn Heart J 2002; 43: 463-474.
29. Yip HK, Wu CJ, Chang HW, Chen MC, Hang CL, Fang CY, et al. Comparison of impact of primary percutaneous transluminal coronary angioplasty and primary stenting on short-term mortality in patients with cardiogenic shock and elevation of prognostic determinants. Am J Cardiol 2001; 78: 1184-1188.
30. Wu CJ, Chang HW, Hung WC, Yang CH, Chen YH, Su CY, et al. N-terminal pro-brain natriuretic peptide is a biomarker of congestive heart failure and predictive of 30-day untoward clinical outcomes in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. Circ J 2006; 70: 163-168.
31. Puren AJ, Fantuzzi G, Gu Y, Su MSS, Dinarello CA. Interleukin-18 (IFNgamma-inducing factor) induces IL-8 and IL-1 beta via TNF alpha production from non-CD14+ human blood mononuclear cells. Clin Invest 1998; 101: 711-721.
32. Kawasaki D, Tsujino T, Morimoto S, Masai M, Masutani M, Ohyanagi M, et al. Plasama interleukin-18 concentration: A novel marker of myocardial ischemia rather than necrosis. Coron Artery Dis 2005; 16: 437-441.
33. Suleiman M, Khatib R, Agmon Y, Mahamid R, Boulos M, Kapeliovich M, et al. Early inflammation and risk of long-term development of heart failure and mortality in survivors of acute myocardial infarction: Predictive role of C-reactive protein. J Am Coll Cardiol 2006; 47: 962-968.
34. James S, Oldgren J, Lindback J, Johnston N, Siegbahn A, Wallentin L. An acute inflammation induced by myocardial damage is super-imposed on chronic inflammation in unstable coronary artery disease. Am Heart J 2005; 149: 619-626.
35. Suleiman M, Aronson D, Reisner SA, Kapeliovich MR, Markiewicz W, Levy Y, et al. Admission C-reactive protein levels and 30-day mortality in patients with acute myocardial infarction. Am J Med 2003; 115: 695-701.
36. Singh RB, Pella D, Neki NS, Chandel JP, Rastogi S, Mori H, et al. Mechanisms of acute myocardial infarction study (MAMIS). Biomed Pharmacother 2004; 58: S111-S115.
37. Yip HK, Wu CJ, Chang HW, Yang CH, Yu TH, Chen YH, et al. Prognostic value of circulating levels of endothelin-1 in patients after acute myocardial infarction undergoing primary coronary angioplasty. Chest 2005; 127: 1491-1497.
38. Kukielka GL, Smith W, Manning AM, Youker KA, Michael LH, Entman ML. Induction of interleukin-6 synthesis in myocardium: Potential role in postreperfusion inflammatory injury. Circulation 1995; 92: 1866-1872.